Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
474.35
-8.65 (-1.79%)
At close: Mar 6, 2026
NSE:AKUMS Market Cap
NSE:AKUMS has a market cap or net worth of 72.62 billion as of March 6, 2026. Its market cap has decreased by -16.16% in one year.
Market Cap
72.62B
Enterprise Value
57.18B
Revenue
42.60B
Ranking
n/a
PE Ratio
22.83
Stock Price
474.35
Market Cap Chart
Since August 6, 2024, NSE:AKUMS's market cap has decreased from 125.32B to 72.62B, a decrease of -42.05%. That is a compound annual growth rate of -29.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 72.62B | 4.62% |
| Dec 31, 2025 | 69.42B | -30.92% |
| Dec 31, 2024 | 100.48B | -19.82% |
| Aug 6, 2024 | 125.32B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 188.13B |
| NATCO Pharma | 170.71B |
| Alembic Pharmaceuticals | 139.07B |
| Cohance Lifesciences | 114.06B |
| Alivus Life Sciences | 111.80B |
| Strides Pharma Science | 76.77B |
| Aarti Pharmalabs | 61.45B |
| Sun Pharma Advanced Research Company | 40.07B |